Europe: Shares inch higher; AstraZeneca tumbles on halting vaccine trials
DeeperDive is a beta AI feature. Refer to full articles for the facts.
[BENGALURU] European shares steadied on Wednesday after hefty declines in the previous session, although sentiment was rattled by AstraZeneca suspending global trials for its Covid-19 vaccine.
AstraZeneca shares slipped 1.3 per cent as it also paused large late-stage trials of its experimental vaccine due to an unexplained illness in a study participant.
The pan-European Stoxx 600 index edged 0.1 per cent higher at 7.10am GMT, with travel and leisure stocks among the biggest decliners in early trading.
REUTERS
Decoding Asia newsletter: your guide to navigating Asia in a new global order. Sign up here to get Decoding Asia newsletter. Delivered to your inbox. Free.
Share with us your feedback on BT's products and services